Efficacy and Safety of Auricular Acupuncture in Depression During the Covid 19 Pandemic
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-50
SponsorUniversidade do Sul de Santa Catarina
About this trial
Participants with moderate depressive symptoms measured by PHQ-9 will be randomized to receive auricular acupuncture. The triple blinded procedure will be conducted in 12 sessions (6 weeks). The primary outcome is the response to the treatment 3 months after inclusion.
Eligibility criteria
Qualifiers
Age between 18 and 50 years old
PHQ-9 score between 10 and 19 (moderate depression)
Availability for sessions
Disqualifiers
None
Trial design
Treatments tested in this trial
- Auricular Acupuncture
Treatment groups
280 Participants
are divided into 2 treatment groupsSponsors and collaborators
Universidade do Sul de Santa Catarina
Lead sponsor
University of Sao Paulo
Collaborator
Source ClinicalTrials.gov